1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Pharmaceutical Analysis & Statistics

Global Pharmaceutical Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

  • All
    • Delve Insight

All regions

1-30 of about 100 reports

Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Familial Amyloid Polyneuropathy - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Familial Amyloid ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Traveler’s Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Traveler’s Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Traveler’s Diarrhea. The ...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • United States
  • World

Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Thrombotic ...

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • United States
  • World

Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Thrombocytopenia. The marketed ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Sedation. The marketed products information ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products fo ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Secondary Hyperparathyroidism. ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Rhinosinusitis. The marketed products ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Rhino-Conjunctivitis. The marketed ...

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • World

Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Retinal Vein Occlusion. The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Restless Legs Syndrome. The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Relapsing Multiple ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Relapsed ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Malignant Glioma. The marketed ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products ...

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • World

Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Pyelonephritis. The marketed products ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Pulmonary Embolism. The marketed ...

  • Blood Disease
  • Cardiovascular Disease
  • Compression Therapy
  • Pharmaceutical
  • World

Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Primary Biliary Cirrhosis. ...

  • Autoimmune Disease
  • Pharmaceutical
  • United States
  • World
  • Demand

Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Premature Labor (Tocolysis). ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Premature Ejaculation. The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Pouchitis. The marketed products information ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Postherpetic Neuralgia. The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World
  • Demand

Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Porphyria. The marketed products information ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Pompe Disease. The marketed products ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Polycythemia. The marketed products ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Phenylketonuria (PKU). The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Non-Small Cell Lung Cancer. ...

  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • United States
  • World

Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Systemic Mastocytosis. The ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Systemic ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 40 pages

"Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Systemic Lupus Erythematosus. ...

  • Pharmaceutical
  • Therapy
  • United States
  • World

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on